The Problem
Traditional methods for preparing biopharmaceutical buffers require significant capital cost, floor space and time, often resulting in production bottlenecks. IPEC was invited to assist a consortium led by NIIMBL and BioPhorum with the design and fabrication of a new platform used to evaluate the effectiveness of on-demand buffer production.
The Solution
The system realized through consortium efforts delivers on-demand buffers using common stock concentrates through in-line dilution, eliminating the need for large centralized buffer preparation facilities. The system is flexible and scalable, making it ideal for use in a variety of settings. A subsequent validation study concluded that BSB meets or exceeds the initial goals for acceptability in cGMP manufacturing.
Innovation+
While the data and design resulting from the initial NIIMBL-BioPhorum study are open-source, IPEC has since incorporated many design improvements into a next-generation platform.